This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (63)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Keiji Iwatsuki, MD; Mikio Ohtsuka, MD; Hiroshi Harada, MD; Gangwen Han, MD; Fumio Kaneko, MD

Arch Dermatol. 1997;133(9):1081-1086.

Abstract
Objective
To elucidate clinicopathologic manifestations of cutaneous lymphoproliferative disorders associated with Epstein-Barr virus (EBV) infection.

Design
Retrospective survey of case series.

Setting
University hospital medical center.

Patients
Sixty-five patients with cutaneous lymphomas and related disorders.

Main Outcome Measures
Detection of EBV genes and EBV-encoded small nuclear RNAs.

Results
Evidence of latent EBV infection was demonstrated in 15 patients: 3 had malignant lymphoma with clinical features mimicking cytophagic histiocytic panniculitis, 6 had facial vesiculopapular eruptions mimicking hydroa vacciniforme, 4 had angiocentric lymphoma, I had histiocytoid lymphoma associated with hemophagocytosis, and I had plasmacytoma. Hypersensitivity to mosquito bites was noted in a patient with hydroa vacciniforme-like eruptions and another with histiocytoid lymphoma. Angiocentric infiltration of atypical lymphoid cells was a common histological feature in the patients with hydroa vacciniforme-like eruptions and angiocentric lymphoma. No evidence of EBV infection was apparent in 19 patients with mycosis fungoides or Sézary syndrome, 7 with adult T-cell leukemia or lymphoma, 3 with lymphomatoid papulosis (type A), and 2 with lymphocytoma cutis.

Conclusion
Patients with EBV-associated cutaneous lymphoproliferative disorders present with unique and diagnostic clinicopathologic features distinct from those of mycosis fungoides or Sézary syndrome.

Arch Dermatol. 1997;133:1081-1086

Author Affiliations
From the Department of Dermatology, Fukushima Medical College, Fukushima, Japan.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pathogenic link between hydroa vacciniforme and epstein-barr virus-associated hematologic disorders.
Iwatsuki et al.
Arch Dermatol 2006;142:587-595.
ABSTRACT | FULL TEXT  

Polymorphism analysis of Epstein-Barr virus isolates of lymphoblastoid cell lines from patients with mycosis fungoides
De Francesco et al.
J Med Microbiol 2004;53:381-387.
ABSTRACT | FULL TEXT  

CD4+ T-Lymphocyte-Induced Epstein-Barr Virus Reactivation in a Patient With Severe Hypersensitivity to Mosquito Bites and Epstein-Barr Virus-Infected NK Cell Lymphocytosis
Asada et al.
Arch Dermatol 2003;139:1601-1607.
ABSTRACT | FULL TEXT  

HVMNE, a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits
Ferrari et al.
Blood 2001;98:2193-2199.
ABSTRACT | FULL TEXT  

A Novel Epstein-Barr Virus-Like Virus, HVMNE, in a Macaca Nemestrina With Mycosis Fungoides
Rivadeneira et al.
Blood 1999;94:2090-2101.
ABSTRACT | FULL TEXT  

Epstein-Barr Virus: A Serial Killer or an Innocent Bystander?
Sangueza
Arch Dermatol 1997;133:1156-1157.
ABSTRACT